Compounds > fluorophosphate
Page last updated: 2024-08-24

fluorophosphate and Bone Diseases, Metabolic

fluorophosphate has been researched along with Bone Diseases, Metabolic in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (80.00)18.2507
2000's1 (20.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Felsenberg, D; Glüer, CC; Mühlenbacher, D; Nickelsen, T; Pavo, I; Payer, J; Quail, D; Reginster, JY; Resch, H; Schmitt, H; Stepan, J1
Beaume-Six, T; Dureau, G; Meunier, PJ; Meys, E; Terreaux-Duvert, F1
Cappagli, B; Ciaponi, M; Gambacciani, M; Genazzani, AR; Piaggesi, L; Rovati, LC; Spinetti, A; Taponeco, F1
Basse-Cathalinat, B; Guaydier-Souquières, G; Kotzki, PO; Loeb, G; Sabatier, JP1
Casez, JP; Haller, B; Jaeger, P; Lippuner, K; Montandon, A1

Trials

4 trial(s) available for fluorophosphate and Bone Diseases, Metabolic

ArticleYear
Effect of raloxifene combined with monofluorophosphate as compared with monofluorophosphate alone in postmenopausal women with low bone mass: a randomized, controlled trial.
    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2003, Volume: 14, Issue:9

    Topics: Adult; Aged; Analysis of Variance; Anthropometry; Bone Density; Bone Diseases, Metabolic; Double-Blind Method; Drug Therapy, Combination; Female; Fluorides; Fractures, Bone; Humans; Middle Aged; Osteoporosis, Postmenopausal; Phosphates; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators

2003
Treatment of postmenopausal vertebral osteopenia with monofluorophospate: a long-term calcium-controlled study.
    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 1995, Volume: 5, Issue:6

    Topics: Adult; Bone Density; Bone Diseases, Metabolic; Bone Remodeling; Calcium; Drug Therapy, Combination; Female; Fluorides; Humans; Lumbar Vertebrae; Middle Aged; Phosphates; Pilot Projects; Postmenopause; Prodrugs; Time Factors

1995
In corticosteroid-treated respiratory diseases, monofluorophosphate increases lumbar bone density: a double-masked randomized study.
    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 1996, Volume: 6, Issue:2

    Topics: Absorptiometry, Photon; Administration, Oral; Adolescent; Adult; Aged; Bone Density; Bone Diseases, Metabolic; Calcium; Double-Blind Method; Drug Therapy, Combination; Female; Fluorides; Humans; Incidence; Lumbar Vertebrae; Male; Middle Aged; Phosphates; Prednisone; Prospective Studies; Respiratory Tract Diseases; Spinal Fractures

1996
Effect of disodium monofluorophosphate, calcium and vitamin D supplementation on bone mineral density in patients chronically treated with glucocorticosteroids: a prospective, randomized, double-blind study.
    Mineral and electrolyte metabolism, 1996, Volume: 22, Issue:4

    Topics: Absorptiometry, Photon; Adult; Aged; Bone Density; Bone Diseases, Metabolic; Calcifediol; Calcium; Double-Blind Method; Female; Fluorides; Glucocorticoids; Humans; Kidney Transplantation; Male; Middle Aged; Phosphates; Prospective Studies

1996

Other Studies

1 other study(ies) available for fluorophosphate and Bone Diseases, Metabolic

ArticleYear
Bone loss after cardiac transplantation: effects of calcium, calcidiol and monofluorophosphate.
    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 1993, Volume: 3, Issue:6

    Topics: Adult; Bone Diseases, Metabolic; Calcifediol; Calcium; Densitometry; Female; Fluorides; Heart Transplantation; Humans; Middle Aged; Osteoporosis; Phosphates; Postoperative Complications; Spinal Fractures; Spine

1993